Oxcarbazepine improves mood in patients with epilepsy.

This study prospectively examined whether continued add-on treatment with oxcarbazepine (OXC) is associated with quantitative improvement in mood and anxiety symptoms in adult patients with partial epilepsy. Depressive symptoms and anxiety were assessed by clinical interview using the Hamilton Depression Rating Scale (HDRS), the Cornell Dysthymia Rating Scale (CDRS), the Beck Depression Inventory (BDI), and the Hamilton Anxiety Rating Scale (HARS). Forty controls (patients with epilepsy treated with antiepileptic drugs other than OXC) and 40 OXC-treated patients were enrolled and completed the study. In our study, a significant improvement in affect, as measured by the CDRS, was demonstrated during the course of OXC treatment for 3 months. HDRS and BDI scores also declined in the OXC-treated group, but these decreases did not reach statistical significance. In addition, 28 of 40 OXC-treated subjects who were dysthymic by CDRS criteria on study entry (score > or =20) demonstrated affective improvement consistent with a treatment-related antidepressant effect (score <20). Although our results do not provide conclusive evidence supporting the specific use of OXC as an antidepressant, the significant decline in dysthymic symptoms in OXC-treated subjects compared with controls lends support to the hypothesis that OXC improves mood.
AuthorsMarianna Mazza, Giacomo Della Marca, Marco Di Nicola, Giovanni Martinotti, Gino Pozzi, Luigi Janiri, Pietro Bria, Salvatore Mazza
JournalEpilepsy & behavior : E&B (Epilepsy Behav) Vol. 10 Issue 3 Pg. 397-401 (May 2007) ISSN: 1525-5050 [Print] United States
PMID17300991 (Publication Type: Clinical Trial, Journal Article)
Chemical References
  • Anticonvulsants
  • Antidepressive Agents
  • Carbamazepine
  • Oxcarbazepine
  • Adult
  • Analysis of Variance
  • Anticonvulsants (therapeutic use)
  • Antidepressive Agents (therapeutic use)
  • Anxiety (drug therapy, etiology)
  • Carbamazepine (analogs & derivatives, therapeutic use)
  • Case-Control Studies
  • Epilepsy (complications, drug therapy)
  • Female
  • Humans
  • Male
  • Middle Aged
  • Mood Disorders (drug therapy, etiology)
  • Oxcarbazepine
  • Psychiatric Status Rating Scales
  • Severity of Illness Index

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!

Choose Username:
Verify Password:
Enter Code Shown: